LOQUS23 Therapeutics Limited
ActiveData to 4 Nov 2026, 03:00
- Company number
- 11914774
- Sector
- Not in a live sector
- SIC group
- Life sciences and health
- Region
- East of England (Great Abington)
- Incorporated
- 29 Mar 2019
- SIC code
- 72110
- Trading name
- Not found
- Website
- loqus23.com Company number on the site, checked 16 Oct 2026
LOQUS23 Therapeutics Limited has 3 priced rounds on record from share allotment filings at Companies House. The latest was allotted on 27 May 2026, raised £15.0m, and was filed on 2 Jun 2026. Data to 4 Nov 2026.
Companies with significant control: Dementia Discovery GP LP. (25 to 50%) and DDF Parallel LLP (25 to 50%). From the PSC register.
3
Priced rounds
Allotted Jul 2023 to May 2026
£38.3m
Cash raised in those rounds
Sum of sterling cash raised in each round, as filed
27 May 2026
Latest round allotted
Filed 2 Jun 2026
Jump to
Funding rounds
Priced equity rounds read from share allotment filings at Companies House, newest first.
| Allotted | First filed | Cash raised | Filing |
|---|---|---|---|
| 27 May 2026Latest | 2 Jun 2026 | £15.0m | Open filing |
| 6 Sep 2024 | 30 Sep 2024 | £20.0m | Open filing |
| 17 Jul 2023 | 11 Sep 2023 | £3.30m | Open filing |
Companies with significant control
Companies with significant control over LOQUS23 Therapeutics Limited, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.
| Holder | Notified | Ceased | Shares held |
|---|---|---|---|
| SV Health Managers LLPControl without shares | 29 Mar 2019 | 29 Mar 2019 | None |
| Dementia Discovery GP LP. | 29 Mar 2019 | n/a | 25 to 50% |
| DDF Parallel LLP | 29 Mar 2019 | n/a | 25 to 50% |
| Novartis Ag | 9 Nov 2021 | 6 Sep 2024 | 50 to 75% |
From the PSC register.
Filings
The latest 6 capital filings other than share allotments (SH01), which are listed under Funding rounds. 16 share filings (SH01, SH03, SH06, SH08 and SH10) have been read for this company.
| Date | Filing | Document |
|---|---|---|
| 19 Mar 2026 | Purchase of own shares (SH03) | Open at Companies House |
| 19 Mar 2026 | Change of share class name (SH08) | Open at Companies House |
| 18 Feb 2026 | Cancellation of shares (SH06) | Open at Companies House |
| 21 Sep 2024 | Resolution | Open at Companies House |
| 21 Sep 2024 | Memorandum and articles (MA) | Open at Companies House |
| 27 Oct 2023 | Resolution | Open at Companies House |
Documents open at Companies House. Bradshaw does not store or re-host them.
About this page
This page shows public register data for LOQUS23 Therapeutics Limited. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.
Last updated 4 Nov 2026